Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Epicutaneous Immunotherapy (EPIT)

FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial...

Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut...

Private Law Firm to Investigate Claims on Behalf of Investors in...

FDA Issues Partial Hold on DBV Viaskin Peanut Patch Trial

DBV Begins Phase 3 Study of Redesigned Viaskin Peanut Patch in...

DBV Announces Positive Topline Results from Phase 3 Trial of Viaskin...

Study Finds Microneedle Delivery Successful in Test of Peanut Allergy Immunotherapy

Viaskin Peanut Patch Therapy Delayed Further as DBV Readies Another Phase...

Safety of Viaskin Peanut Patch Therapy Improved Over 3-Year Study

FDA Wants More Viaskin Peanut Data Resulting in Further Approval Delays

Follow Us

Your School On Our Map

Put Your School on the Map